|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.05 BRL | +1.62% |
|
+1.03% | -23.78% |
| 06-29 | Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program | MT |
| 06-29 | Lilly, Regeneron selected for US program to review new manufacturing plants faster | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.57% | +4.09% | +4.09% | +1.35% | +9.81% | +56.93% | +222.66% | +197.19% | +289.88% | 57.29B | |
| -3.94% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | - | 43.45B | |
| +2.35% | +2.16% | +24.70% | -17.37% | -31.96% | -50.69% | -57.48% | -58.56% | +5.11% | 38.02B | |
| -0.26% | +9.57% | +10.23% | +17.85% | +22.77% | +72.04% | -24.15% | -37.60% | -10.65% | 31.98B | |
| +0.47% | +14.80% | +48.40% | +37.85% | +137.47% | +153.82% | -42.36% | -70.20% | - | 27.66B | |
| -1.13% | +8.58% | +17.18% | +20.44% | +14.77% | +66.46% | +82.10% | +34.74% | +41.74% | 22.91B | |
| -0.56% | +4.05% | -4.50% | -6.24% | +4.39% | +1.53% | +168.92% | -12.09% | - | 17.74B | |
| -0.13% | -0.94% | +4.48% | +17.80% | +38.82% | +60.31% | +119.58% | +196.06% | +349.42% | 16.45B | |
| +3.43% | +8.52% | +12.41% | +0.30% | -2.63% | +72.49% | +333.02% | +22.18% | - | 14.1B | |
| -3.22% | +8.41% | -2.17% | +5.71% | -19.69% | -2.96% | +740.51% | +417.56% | +5,820.73% | 12.95B | |
| +1.51% | +1.16% | +4.39% | +44.82% | +34.02% | +134.48% | +240.62% | +262.84% | +3,146.29% | 12.41B | |
| -1.71% | +9.25% | +20.27% | +43.88% | +50.75% | +170.38% | +216.58% | +446.57% | - | 11.15B | |
| -0.78% | +1.27% | -0.12% | +1.29% | -3.72% | +4.09% | -33.99% | -31.42% | -26.45% | 11.15B | |
| +6.73% | +17.40% | +19.48% | +1.87% | +29.25% | +41.95% | +350.53% | +276.87% | - | 6.56B | |
| -0.44% | +0.13% | -3.45% | +0.04% | -16.26% | -13.43% | -23.68% | -60.77% | -55.77% | 6.27B | |
| +4.60% | +21.04% | +53.85% | +116.50% | +224.34% | +179.64% | +402.83% | -22.79% | - | 6.13B | |
| -2.26% | +2.80% | -8.70% | -25.40% | -30.15% | -28.58% | +114.61% | +75.94% | +112.45% | 5.51B | |
| -1.14% | -5.40% | -22.19% | -32.15% | -39.99% | -55.79% | -59.61% | -78.88% | - | 5.07B | |
| -1.41% | -0.86% | +8.57% | -11.31% | -16.62% | +3.61% | +47.43% | -46.74% | - | 5.04B | |
| Average | +0.08% | +5.70% | +11.90% | +13.49% | +23.39% | +47.65% | +149.33% | +81.58% | +967.27% | 18.52B | |
| Weighted average by Cap. | -0.30% | +5.30% | +16.12% | +13.89% | +23.58% | +50.02% | +118.42% | +74.23% | +640.01% |
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
